• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样β蛋白片段25 - 35和31 - 35增强大鼠海马CA1区体内的长时程抑制。

Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo.

作者信息

Cheng Li, Yin Wen-Juan, Zhang Jun-Fang, Qi Jin-Shun

机构信息

Department of Neurobiology, Key Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.

出版信息

Synapse. 2009 Mar;63(3):206-14. doi: 10.1002/syn.20599.

DOI:10.1002/syn.20599
PMID:19072840
Abstract

Amyloid beta-protein (Abeta) is thought to be responsible for the deficit of learning and memory in Alzheimer's disease (AD), possibly through interfering with synaptic plasticity in the brain. It has been reported that Abeta fragments suppress the long-term potentiation (LTP) of synaptic transmission. However, it is unclear whether Abeta fragments can regulate long-term depression (LTD), an equally important form of synaptic plasticity in the brain. The present study investigates the effects of Abeta fragments on LTD induced by low frequency stimulation (LFS) in the hippocampus in vivo. Our results showed that (1) prolonged 1-10 Hz of LFS all effectively elicited LTD, which could persist for at least 2 h and be reversed by high frequency stimulation (HFS); (2) the effectiveness of LTD induction depended mainly on the number of pulses but not the frequency of LFS; (3) pretreatment with Abeta fragment 25-35 (Abeta(25-35), 12.5 and 25 nmol) did not change baseline field excitatory postsynaptic potentials but dose-dependently potentiated LTD; (4) Abeta fragment 31-35 (Abeta(31-35)), a shorter Abeta fragment than Abeta(25-35), also dose-dependently strengthened LFS-induced hippocampal LTD. Thus, the present study demonstrates the enhancement of hippocampal LTD by Abeta in in vivo condition. We propose that Abeta-induced potentiation of LTD, together with the suppression of LTP, will result in the impairment of cognitive function of the brain.

摘要

淀粉样β蛋白(Aβ)被认为是导致阿尔茨海默病(AD)学习和记忆缺陷的原因,可能是通过干扰大脑中的突触可塑性。据报道,Aβ片段会抑制突触传递的长时程增强(LTP)。然而,目前尚不清楚Aβ片段是否能够调节长时程抑制(LTD),这是大脑中同样重要的一种突触可塑性形式。本研究调查了Aβ片段对体内海马体中低频刺激(LFS)诱导的LTD的影响。我们的结果表明:(1)延长至1 - 10 Hz的LFS均能有效诱发LTD,其可持续至少2小时,并可被高频刺激(HFS)逆转;(2)LTD诱导的有效性主要取决于脉冲数量而非LFS的频率;(3)用Aβ片段25 - 35(Aβ(25 - 35),12.5和25 nmol)预处理并未改变基线场兴奋性突触后电位,但能剂量依赖性地增强LTD;(4)Aβ片段31 - 35(Aβ(31 - 35)),一种比Aβ(25 - 35)更短的Aβ片段,也能剂量依赖性地增强LFS诱导的海马体LTD。因此,本研究证明了在体内条件下Aβ可增强海马体LTD。我们提出,Aβ诱导的LTD增强,连同对LTP的抑制,将导致大脑认知功能受损。

相似文献

1
Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo.淀粉样β蛋白片段25 - 35和31 - 35增强大鼠海马CA1区体内的长时程抑制。
Synapse. 2009 Mar;63(3):206-14. doi: 10.1002/syn.20599.
2
Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.精氨酸加压素可预防β-淀粉样蛋白在体内诱导的大鼠海马长时程增强损伤。
Neurosci Lett. 2009 Feb 6;450(3):306-10. doi: 10.1016/j.neulet.2008.11.053. Epub 2008 Nov 28.
3
Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.蛋白激酶C介导β-淀粉样蛋白片段31-35在体内对海马晚期长时程增强的抑制作用。
Neurobiol Learn Mem. 2009 Mar;91(3):226-34. doi: 10.1016/j.nlm.2008.11.004. Epub 2008 Dec 23.
4
Amyloid beta-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo.淀粉样β蛋白片段31 - 35抑制大鼠体内海马CA1区的长时程增强效应。
Synapse. 2006 Sep 15;60(4):307-13. doi: 10.1002/syn.20302.
5
The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo.白细胞介素-1受体拮抗剂对大鼠体内CA1区β淀粉样蛋白介导的长时程增强抑制作用的影响。
Hippocampus. 2009 Jul;19(7):670-6. doi: 10.1002/hipo.20542.
6
Coexistence of muscarinic long-term depression with electrically induced long-term potentiation and depression at CA3-CA1 synapses.毒蕈碱型长时程抑制与CA3-CA1突触处电诱导的长时程增强和抑制共存。
J Neurophysiol. 2006 Dec;96(6):3114-21. doi: 10.1152/jn.00144.2006. Epub 2006 Sep 27.
7
alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats.α7烟碱型乙酰胆碱受体作为挽救β-淀粉样蛋白注射大鼠海马长时程增强诱导缺陷的靶点。
Neuropharmacology. 2006 Feb;50(2):254-68. doi: 10.1016/j.neuropharm.2005.09.018. Epub 2005 Dec 1.
8
Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.阿尔茨海默病淀粉样β肽A-β25-35阻断腺苷酸环化酶介导的海马长时程增强形式。
Ann N Y Acad Sci. 2007 Feb;1097:58-63. doi: 10.1196/annals.1379.020.
9
Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons.β-淀粉样蛋白损害海马CA1锥体神经元长期增强效应的机制独立于N-甲基-D-天冬氨酸受体或电压依赖性钙通道。
Neurosci Lett. 2005 Dec 31;391(1-2):1-6. doi: 10.1016/j.neulet.2005.08.024. Epub 2005 Sep 9.
10
Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.Val8- 胰高血糖素样肽-1 可预防 Aβ1-40 诱导的大鼠海马晚期长时程增强和空间学习能力损害。
Neuroscience. 2010 Nov 10;170(4):1239-48. doi: 10.1016/j.neuroscience.2010.08.028. Epub 2010 Aug 19.

引用本文的文献

1
Anti-Inflammatory Peptide Prevents Aβ-Induced Inflammation in Rats via Lipoxygenase Inhibition.抗炎肽通过抑制脂氧合酶预防大鼠β淀粉样蛋白诱导的炎症。
Cells. 2025 Jun 23;14(13):957. doi: 10.3390/cells14130957.
2
Resveratrol mitigates activated astrocytes and microglia preventing Alzheimer's Disease (AD) progression and facilitates neuronal communication in Amyloid-β25-35 induced rat model for AD: A special emphasis on non-neuronal involvement in AD pathophysiology.白藜芦醇可减轻活化的星形胶质细胞和小胶质细胞,预防阿尔茨海默病(AD)进展,并促进淀粉样β蛋白25-35诱导的AD大鼠模型中的神经元通讯:特别强调非神经元因素在AD病理生理学中的作用。
Psychopharmacology (Berl). 2025 May 27. doi: 10.1007/s00213-025-06814-x.
3
The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease.
选择性丁酰胆碱酯酶抑制剂 UW-MD-95 在阿尔茨海默病的药理学小鼠模型中显示出症状改善和神经保护作用。
CNS Neurosci Ther. 2024 Jun;30(6):e14814. doi: 10.1111/cns.14814.
4
Decoding the Roles of Amyloid-β (1-42)'s Key Oligomerization Domains toward Designing Epitope-Specific Aggregation Inhibitors.解析淀粉样β蛋白(1-42)关键寡聚化结构域在设计表位特异性聚集抑制剂中的作用
JACS Au. 2023 Mar 2;3(4):1065-1075. doi: 10.1021/jacsau.2c00668. eCollection 2023 Apr 24.
5
Amyloid Aβ Aggregates Say 'NO' to Long-Term Potentiation in the Hippocampus through Activation of Stress-Induced Phosphatase 1 and Mitochondrial Na/Ca Exchanger.淀粉样蛋白 Aβ 聚集物通过激活应激诱导的磷酸酶 1 和线粒体 Na/Ca 交换器对海马体中的长时程增强说“不”。
Int J Mol Sci. 2022 Oct 6;23(19):11848. doi: 10.3390/ijms231911848.
6
Fyn Kinase Activity and Its Role in Neurodegenerative Disease Pathology: a Potential Universal Target?Fyn激酶活性及其在神经退行性疾病病理学中的作用:一个潜在的通用靶点?
Mol Neurobiol. 2021 Nov;58(11):5986-6005. doi: 10.1007/s12035-021-02518-3. Epub 2021 Aug 25.
7
The two faces of synaptic failure in App knock-in mice.APP 敲入小鼠突触故障的两面性。
Alzheimers Res Ther. 2020 Aug 24;12(1):100. doi: 10.1186/s13195-020-00667-6.
8
Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.利鲁唑:通过靶向 WNT/β-连环蛋白通路治疗阿尔茨海默病的策略。
Aging (Albany NY). 2020 Feb 8;12(3):3095-3113. doi: 10.18632/aging.102830.
9
Hippocampal long-term synaptic depression and memory deficits induced in early amyloidopathy are prevented by enhancing G-protein-gated inwardly rectifying potassium channel activity.增强 G 蛋白门控内向整流钾通道活性可预防早期淀粉样变诱导的海马长时程突触抑制和记忆缺陷。
J Neurochem. 2020 May;153(3):362-376. doi: 10.1111/jnc.14946. Epub 2020 Jan 30.
10
Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models.tau 病理而非 aβ 病理增强 AD 小鼠模型中 NMDA 受体依赖的沉寂后易化。
Acta Neuropathol Commun. 2019 Dec 9;7(1):202. doi: 10.1186/s40478-019-0813-4.